In breast cancer, activated c-Abl kinase promotes cancer progression [4], [6], while inhibition of c-Abl blocks the transforming phenotypes by suppressing anchorage-independent growth, inducing apoptosis, and inhibiting cell proliferation [5]. Here, ABL1 is linked to breast carcinoma.